Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Reggie Groves, CEO, REVA Medical Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Reva develops bioresorbable coronary scaffolds for the treatment of cardiovascular disease.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Data-Driven Management: Strategies for Success with Dr. Bülent Dal | Dr. Bülent Dal, CEO, Obase Bilgisayar ve Danışmanlık Hizmetleri.
00:10:00
A community of founders & operators who care deeply about the next generation of local entrepreneurs|Scott Hartley,Co-Founder and General Partner, The Fund NY,The Fund
00:10:00
Gold Investing_ Understanding Project Stages | Nick Jefferies , Group Chief Executive at Discovery Group (IE)
00:10:00
Cristian Jimenez on Pride and Inclusivity at Boart Longyear
00:10:00
Investing Along the Z-Axis with Airbus Ventures|Lewis Pinault,Partner,Asia Japan & The Pacific,Airbus Ventures
00:10:00
Symbol Mining: Pioneering High-Grade Zinc Production in Nigeria
00:10:00
PureCycle Technologies CEO Discusses Launch of Flagship Facility and Global Agreements | Dustin Olson, CEO , Pure Cycle Corp.
00:10:00
Enrique Escalante Addresses GCCA at Atlanta CEO Gathering | Enrique Escalante - CEO of GCC SAB de
00:10:00
Inside Cyient DLM Ltd.'s Role in India's Thriving Electronics Manufacturing Revolution | KRISHNA BODANAPU , Chairman, Cyient DLM Ltd.
00:10:00
In-depth Insights from PNC CEO Bill Demchak on Banking and Economic Trends | Bill Demchak, CEO, PNC Financial Services .
00:10:00
Homophobia in Drag: Insights on Pride and LGBTQ+ Politics|Ben Appel,Professor,Michigan State University
00:10:00
spectrum of technical backgrounds and the versatility to invest at any stage|Deena Shakir,Partner,Lux Capital